Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Antin

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Stem Cells (Dayton, Ohio)|March 10, 2001
Peripheral blood stem cells for allogeneic transplantation: a reviewC Cutler, J H Antin
Bone Marrow Transplantation|July 27, 2004
Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantationC Cutler, J H Antin
Hematology/Oncology Clinics of North America|April 2, 1998
Infusion of donor peripheral blood mononuclear cells to treat relapse after transplantation for chronic myelogenous leukemiaD L Porter, J H Antin
Hematology/Oncology Clinics of North America|April 1, 1993
Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromesK K Ballen, J H Antin
Blood|December 15, 1992
Cytokine dysregulation and acute graft-versus-host diseaseJ H Antin, J L Ferrara
Leukemia & Lymphoma|April 1, 1995
Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantationD L Porter, J H Antin
Annual Review of Medicine|March 12, 1999
The graft-versus-leukemia effects of allogeneic cell therapyD L Porter, J H Antin
Cancer Treatment and Research|January 1, 1997
Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusionsD L Porter, J H Antin
Clinics in Geriatric Medicine|November 1, 1985
Acute leukemias, myelodysplasia, and lymphomasJ H Antin, D S Rosenthal
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1989
Bone marrow progenitor cells induce a regulatory autologous proliferative T lymphocyte responseS G Emerson, J H Antin
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Stem Cells (Dayton, Ohio)|March 10, 2001
Peripheral blood stem cells for allogeneic transplantation: a reviewC Cutler, J H Antin
Bone Marrow Transplantation|July 27, 2004
Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantationC Cutler, J H Antin
Hematology/Oncology Clinics of North America|April 2, 1998
Infusion of donor peripheral blood mononuclear cells to treat relapse after transplantation for chronic myelogenous leukemiaD L Porter, J H Antin
Hematology/Oncology Clinics of North America|April 1, 1993
Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromesK K Ballen, J H Antin
Blood|December 15, 1992
Cytokine dysregulation and acute graft-versus-host diseaseJ H Antin, J L Ferrara
Leukemia & Lymphoma|April 1, 1995
Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantationD L Porter, J H Antin
Annual Review of Medicine|March 12, 1999
The graft-versus-leukemia effects of allogeneic cell therapyD L Porter, J H Antin
Cancer Treatment and Research|January 1, 1997
Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusionsD L Porter, J H Antin
Clinics in Geriatric Medicine|November 1, 1985
Acute leukemias, myelodysplasia, and lymphomasJ H Antin, D S Rosenthal
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1989
Bone marrow progenitor cells induce a regulatory autologous proliferative T lymphocyte responseS G Emerson, J H Antin
Pageof 12